STOCKS TELEGRAPH

Tag: Ocugen stock

  • Why Is Ocugen (OCGN) Stock Increasing Today?

    The shares of Ocugen Inc. (OCGN) are up 3.58% to $6.67 in early trading this morning. The Ocugen stock was down by -4.17% to $6.44 at the end of the last trading session. There were 13.28 million shares traded in OCGN stock yesterday. That was below the volume of 44.31 million shares in a daily average for the past 50 days.

    OCGN stock has declined 10.06 percent in the last five days; however, it has gained 5.06% over the past month. Over the last three months, the stock price of OCGN has shed -6.67% and is up 251.91% so far this year. In response to a submission to the Canadian health authority, OCGN stock is rising.

    What OCGN has been submitting?

    As a biopharmaceutical company, Ocugen aims to discover, develop, and commercialize gene therapies for blindness diseases and to develop a vaccine against COVID-19. OCGN’s breakthrough platform for gene therapy, which treats multiple retinal diseases with one drug, has the potential to treat multiple diseases with the same drug.

    With OCGN’s novel biologic product candidate, patients with diseases like wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy will be able to receive better treatment options. Bharat Biotech’s COVAXIN, a vaccine candidate for COVID-19, is being co-developed by OCGN in the United States and Canada.

    A rolling submission for COVAXIN has been made to Health Canada by Ocugen, announced the company in a press release today. Following the publication of results from Bharat Biotech’s Phase 3 clinical trial, which showed efficacy and safety in nearly 25,800 adults, OCGN intends to make this move.

    The Minister of Health recommended and accepted the rolling submission process relating to the importation, sale and advertising of drugs for use with COVID-19 and transitioned to the New Drug Submission for COVID-19, which will allow companies to submit safety and efficacy information as it becomes available. Often referred to as rolling reviews, this allows Health Canada to begin its review immediately as new information becomes available, allowing the overall review process to move faster.

    How OCGN will proceed?

    In the rolling submission, Ocugen (OCGN) is represented by its affiliate, Vaccigen, Ltd. OCGN must submit evidence that supports the safety, effectiveness, and quality of their product to Health Canada for review. OCGN will work with Health Canada to bring another safe and effective option for the fight against COVID-19 and its Delta variant, and will be supporting Health Canada for their upcoming review of COVAXIN.

  • Ocugen, Inc. (OCGN) stock falls in Pre-Market today: Why is it so?

    Ocugen, Inc. (OCGN) stock falls in Pre-Market today: Why is it so?

    Shares of Ocugen, Inc. (OCGN) stock were down in the per market trading session today after recording the gain of 6.69% with an $11.96 per share price. OCGN stock price went down by 3.60% to drop at $11.53 a share at the time of this writing. There is no particular activity by the Ocugen today however OCGN stock on April 28, 2021, announced the closing of a previously announced registered direct offering of common stock. Let’s explore more about OCGN stock.

    What’s happening?

    There is no specific reason behind the declining stock price of the OCGN stock today. No signs of analysts’ downgrade or shrank targeted per share price of the OCGN stock have been in the recent news. The most recent activity by the Ocugen stock is that it announced the closing of the previously announced registered direct offering of its common stock. OCGN stock offered 10 million shares of its common stock to healthcare-focused institutional investors at a purchase price of $10 per share. The gross proceeds resulting from this offering were roughly $100 million without the deduction of placement agent’s fees and other offering-related expenses which Ocugen has to pay.

    Net proceeds resulted from this offering would be used for general corporate purposes and capital expenditures by the OCGN stock. Moreover, part of the proceeds will also be used in the working capital as well as general and administrative expenses by the Ocugen stock.

    COVID-19 Vaccine Development:

    About a week ago, OCGN’s partner Bharat Biotech announced positive data for the second interim analysis of the phase 3 study of Covaxin. According to the data, Covaxin showed 100% efficacy against severe COVID-19 disease, and efficacy of 78% was shown by Covaxin candidate against mild, moderate, and severe COVID-19 disease. After getting encouraging results from the phase 3 study, Ocugen stock is hoping to win the EUA for Covaxin. Currently, Covaxin has been playing a major role in the fight against deadly pandemic in India.

    Conclusion:

    OCGN stock is gloomy so far in the stock market but it showed considerable overall growth in recent times.The positive results of the phase 3 study of Covaxin are the main reason behind this growth but still OCGN stock is lagging in the race of COVID-19 vaccine development as companies like Pfizer, Moderna, and Johnson& Johnson have already contracted the U.S government for the supply of millions of vaccine doses.

  • Ocugen (OCGN) Stock Price Increased by 270% On A Year To Date Basis. Here’s What Happened

    Ocugen (OCGN) Stock Price Increased by 270% On A Year To Date Basis. Here’s What Happened

    Ocugen (OCGN) stock is a relatively new biotechnology company specializing in diverse and lucrative fields such as gene therapy and Covid 19 vaccines. In February, OCGN made a contractual agreement with Bharat Biotech to produce the Covaxin Covid-19 vaccine, which showed minimal side effects and had an 81% efficacy rate in phase 3 clinical trial in India soaring OCGN Stock price by 270%. Ocugen agreement stipulates that it will commercialize the vaccine in the U.S, targeting a huge demographic and capturing a staggering 45% of the profits from its sale.

    The vaccine produced by OCGN is an inactivated vaccine. Primarily, an inactivated or dead form of the SARS-CoV-2 virus is inserted into the human bloodstream. Afterwards antibody production is started by the immune system and the body ‘Learns’ the defense mechanism. Hence if an infection occur, the immune system can respond swiftly and efficiently.

    Now What

    Financially, the company consists of over $24 million in capital and has approximately $2.1 million in debt. In 2020, its net losses were $21.8 million, however new OCGN stock can be issued to generate capital and new income from vaccines could further help Ocugen to diversify its pipeline.

    Furthermore, Pfizer, Moderna, and AstraZeneca have already started mass production of their vaccines, hence OCGN can have a hard time grabbing a significant share in the saturated market. However, Bharat Biotech claims that Covaxin demonstrates “significant immunogenicity against the rapidly emerging variants.” giving OCGN product line distinctive competency over other vaccines which can produce a potentially huge financial surplus.

    Conclusion

    OCGN has invested in a very lucrative market of vaccines especially amongst the time of a pandemic. A strategic relationship with Bharat Biotech combined with an 81% efficacy rate of the vaccine has peaked investor interest with speculations of high capital gains in the near future.

  • Early Morning Vibes: Check Out These 4 hot Stocks Right Now

    Early Morning Vibes: Check Out These 4 hot Stocks Right Now

    Stock markets recovered strongly from the price dip at the end of January last week. In New York, the indices even managed to set new all-time highs on the boards. On Friday, the S&P 500 closed 0.39% higher at 3,886 points and the Nasdaq celebrated the weekend with a gain of 0.57% on 13,856 points.

    The unemployment figures on Friday showed that the labor market is slowly but surely going to recover somewhat. In January, 49,000 jobs were added in the private sector and the unemployment rate fell to 6.3%. Wall Street had previously expected more jobs, but economists assumed an unchanged unemployment rate at 6.7%. Still, the numbers were not very positive. Unemployment fell mainly because 406,000 people gave up their job search. The participation rate thus fell to 61.4%. This is a bad sign and indicates that the US job market is in bad shape.

    To support the US economy, Joe Biden is currently preparing a $ 1,900 billion corona support package. The package includes $ 1,400 in incentive vouchers, supplemental unemployment benefits, and Covid-19 vaccination and testing funds. Treasury Secretary Janet Yellen said on Sunday that if Biden’s stimulus plan is passed, the US could return to full employment by 2022.

    The S&P 500 nevertheless managed to close in the green for five days in a row and appears to continue this series today. Futures are up approximately 0.4% and there is little on the agenda to change that. Figures from Twitter, Uber, Walt Disney, and Coca-Cola will follow later this week. Furthermore, inflation figures from the US, China, and Germany are on the agenda.

    Today Top Movers

    Aurora Mobile Ltd (JG) grew over 25.50% at $6.25 in pre-market trading ‎today after declaring a partnership agreement with iQIYI (IQ)‎, to develop a smart advertising and marketing ecosystem. ‎

    Ocugen, Inc (OCGN) stock moved up 68.76 percent to $8.86 in the pre-market ‎trading.‎ The company recently declared a $23 million registered direct offering of common stock priced at a premium to market. ‎

    Westport Fuel Systems Inc (WPRT) gained over 49.13% at $12.90 in pre-market ‎trading on Monday.‎ ‎

    Sundial Growers Inc (SNDL) is up more than 0.88% at $1.14 in pre-market ‎hours ‎Monday ‎February 08, 2021.‎

    Top Upgrades & Downgrades

    RBC Capital turned bullish on The Hershey Company (HSY), upgrading the stock to “Outperform” and assigning a $170.0 price target, representing a potential upside of 15.95% from Friday’s close. 

    The Estee Lauder Companies Inc. (EL) has won the favor of Jefferies’s equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $310.0, suggesting a 13.59% additional upside for the stock. 

    CorEnergy Infrastructure Trust Inc. (CORR) received an upgrade from analysts at DA Davidson, who also set their one-year price target on the stock to $9.5. They changed their rating on CORR to Neutral from Underperform in a recently issued research note. 

    Earlier Monday Raymond James reduced its rating on Iridium Communications Inc. (IRDM) stock to Market Perform from Outperform. 

    UBS analysts reduced their investment ratings, saying in research reports covered by the media that its rating for ViacomCBS Inc. (VIAC) has been changed to Sell from Neutral. 

    Analysts at BofA downgraded Las Vegas Sands Corp. (LVS)’s stock to Neutral from Buy Monday.

    Latest Insider Activity

    Zomedica Corp. (ZOM) Director MACLEOD CHRISTOPHER ROSS announced the sale of shares taking place on Feb 03 at $1.10 for some 6,400 shares. The total came to more than $7047.

    Zynga Inc. (ZNGA) Director DUGAN REGINA E sold on Feb 04 a total 217,319 shares at $10.27 on average. The insider’s sale generated proceeds of almost $91917.

    Harley-Davidson Inc. (HOG) President and CEO ZEITZ JOCHEN declared the purchase of shares taking place on Feb 04 at $32.47 for some 30,800 shares. The transaction amount was around $1.0 million.

    Amicus Therapeutics Inc. (FOLD) Director WHITMAN BURKE W bought on Feb 01 a total 41,467 shares at $19.09 on average. The purchase cost the insider an estimated $28,637.

  • Why Ocugen, Inc. (OCGN) looks set to accumulate more gains?

    Why Ocugen, Inc. (OCGN) looks set to accumulate more gains?

    Ocugen, Inc. (OCGN) was up another 60% in aftermarket trading on Friday after the company announced it had signed definitive agreements for the sale of an aggregate of 3,000,000 shares of common stock to healthcare-focused institutional investors. The shares were offered in a registered direct offering at $7.65 per share. The offering will close on or about February 10, 2021, pending the satisfaction of the usual closing conditions. The exclusive placement agent for the issuer is H.C. Wainwright & Co.

    Before deducting placement agent’s fees and other offering expenses Ocugen will receive approximately $23 million in gross proceeds. Ocugen intends to use its net proceeds from the offering to fund working capital, capital expenditures, and its general and administrative expenses.

    OCGN is already up 200% over week

    The stock skyrocketed around 200% last week after the biopharmaceutical firm struck a deal to develop a promising coronavirus vaccine candidate to be used in the United States. The deal prompted Roth Capital analyst ZegbehJallah to raise the firm’s price target on Ocugen from $1 to $8. Based on the research note, Jallah explains that the terms of the deal are favorable, including no upfront payment so that the company can start off with a positive cash flow.

    What Was Behind The Happy Weekend

    On Friday, Ocugen shares rose 61.5%, following another upbeat analyst note.

    SwayampakulaRamakanth of H.C. Wainwright increased his rating for Ocugen’s stock to buy from neutral on Thursday and forecasted a $4.50 target price for the stock. Ramakanth supported the recent deal between Ocugen and India’s Bharat Biotech, which could potentially deliver Covaxin, a candidate vaccine for COVID-19, to the U.S. market.

    Ramakanth suggests Covaxin could induce a greater level of immunity and better protection against new strains of coronavirus than the COVID-19 vaccine that has been given an emergency use authorization in the U.S. He also emphasized the logistical advantages of covaxin’s less onerous storage requirements, thereby enhancing its competitive edge.

  • Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Futures for major US stock indices rose on Thursday in anticipation of labor market statistics and a new portion of corporate reporting, according to trading data.

    Futures on the Dow Jones Industrial Average (DJIA) grew by 0.1%, to 30.660 points, on the NASDAQ high-tech index – by 0.41%, to 13449 points, on the broad market S&P 500 index – by 0.16%, up to 3829.88 points.

    Investors are watching for signs that the US economic recovery will continue, despite the large number of cases of infection with coronavirus and new strains of it, against which existing vaccinations may be less effective, which is fraught with new restrictive measures.

    In this light, the market is interested in the statistics of the initial jobless claims, which will be published later on Thursday. Analysts expect a decrease in this number by 17 thousand last week compared to the previous one, to 830 thousand applications.

    In addition, traders are waiting for a new portion of corporate reporting in the United States. For example, investment company Carlyle Group, pharmaceutical Bristol-Myers Squibb and tobacco Philip Morris International should disclose their financials for the past quarter before the opening of trading, and the automaker Ford Motor and Snap, which owns the social networking app Snapchat, are planning to publish a profit report and losses after their closure.

    Today Top Movers

    Bilibili Inc (BILI) share price jumped 11.14% to $150.25 during the early morning ‎trading session on ‎Thursday.‎ As of Q3 2020, Bilibili reported that its total number of monthly active users increased 54% year-over-year to 197.2 million. And the total paying users increased 89% to 15 million.‎

    Cassava Sciences Inc (SAVA) gained over 42.00% at $124.89 in pre-market ‎trading on Thursday.‎ The firm recently declared results of an interim analysis from an open-label study of simufilam, its lead drug candidate for the treatment of Alzheimer’s disease. ‎

    Onconova Therapeutics Inc (ONTX) grew over 6.70% at $0.90 in pre-market trading ‎today. Recently ONTX being granted a European patent for “The Treatment Of Hematological Cancer Refractory To An Anti-Cancer Agent.” 

    DraftKings Inc (DKNG) stock moved up 1.01 percent to $60.72 in the pre-market ‎trading.‎

    Top Upgrades & Downgrades

    Roth Capital turned bullish on Ocugen Inc. (OCGN), upgrading the stock to “Buy” and assigning a $1.0 price target, representing a potential upside of 60.14% from Wednesday’s close. 

    STERIS plc (STE) has won the favor of KeyBanc’s equity research team. The firm upgraded the shares from Sector Weight to Overweight and moved their price target to $224.0, suggesting a 22.45% additional upside for the stock. 

    FireEye Inc. (FEYE) received an upgrade from analysts at BofA, who also set their one-year price target on the stock to $27. They changed their rating on FEYE to Buy from Neutral in a recently issued research note. 

    Earlier Thursday HC Wainwright & Co. reduced its rating on GW Pharmaceuticals plc (GWPH) stock to Neutral from Buy and assigned the price target to $220.0. With shares trading at around $211.37, the Wall Street firm thinks GW Pharmaceuticals plc’s stock could add than 4.08%. 

    KeyBanc analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Murphy Oil Corporation (MUR) has been changed to Sector Weight from Overweight. 

    Analysts at Oddo BHF downgraded GlaxoSmithKline plc (GSK)’s stock to Neutral from Buy Thursday.

    Latest Insider Activity

    Apple Inc. (AAPL) Director LEVINSON ARTHUR D announced the sale of shares taking place on Feb 02 at $135.60 for some 3,416 shares. The total came to more than $0.46 million. 

    Koss Corporation (KOSS) VP – Marketing & Product Koss Michael J Jr sold on Feb 02 a total 46,000 shares at $25.98 on average. The insider’s sale generated proceeds of almost $0.36 million. 

    MannKind Corporation (MNKD) Chief Executive Officer Castagna Michael declared the purchase of shares taking place on Jan 31 at $1.33 for some 5,000 shares. The transaction amount was around $6650. 

    Texas Instruments Incorporated (TXN) Director Craighead Martin S bought on Jan 28 a total 21,388 shares at $166.91 on average. The purchase cost the insider an estimated $997,294.

    Important Earnings

    Top US earnings releases scheduled for today include Nokia Corporation (NYSE: NOK). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.13 per share from revenues of $7.43B in the three-month period. 

    Analysts expect Ford Motor Company (NYSE: F) to report a net income (adjusted) of -$0.07 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $33.89B. 

    Snap Inc. (SNAP), due to announce earnings after the market closes today, is expected to report earnings of $0.07 per share from revenues of $857.39M recently concluded three-month period.

  • 24 stocks making the biggest moves premarket today

    24 stocks making the biggest moves premarket today

    ‎Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-‎market trading. The company recently granted 180-day extension by Nasdaq to regain ‎compliance with bid price rule. The most recent rating by Ladenburg Thalmann, on September ‎‎24, 2020, is a Buy.‎

    ‎Jaguar Health Inc. (JAGX) grew over 14.11% at $0.93 in pre-market trading ‎today.‎

    ‎Castor Maritime Inc. (NASDAQ: CTRM) shares are trading up 5.41% at $0.195 ‎at the time of writing after revealing the pricing of $18.0 million registered direct offering. ‎Company’s 52-week ranged between $0.11 to $2.60.‎

    ‎Bit Digital Inc. (BTBT), a Software – Application company, rose about 18.3% at ‎‎$25.92 ‎in pre-market trading Monday.‎

    ‎Canaan Inc. (CAN) stock moved up 18.72 percent to $7.04 in the pre-market ‎trading.‎

    ‎Ebang International Holdings Inc. (EBON) stock soared 25.7% to $7.63 in the ‎pre-market trading after declared that the Company expects to commence public testing of its ‎cryptocurrency exchange and officially launch the exchange in the first quarter of 2021.‎

    ‎Riot Blockchain Inc. (NASDAQ: RIOT) shares are trading up 7.18% at $18.21 ‎at the time of writing. Company’s 52-week ranged between $0.51 to $18.16.‎

    ‎Marathon Patent Group Inc. (MARA) stock moved up 10.92 percent to $11.58 ‎in the pre-market trading following the declaration from the firm that that it has successfully ‎completed its $200 million shelf offering by utilizing its at-the-market (ATM) facility. ‎

    ‎Seanergy Maritime Holdings Corp. (SHIP) lost over -2.7% at $0.5231 in pre-‎market trading Monday January 04, 2021.‎

    ‎Li Auto Inc. (LI) gained over 4.68% at $30.18 in pre-market ‎trading ‎Monday ‎January ‎‎04, 2021 after reporting that the Company delivered 6,126 Li ONEs in ‎December ‎‎2020, ‎representing an ‎increase of 31.9% month-over-month and 529.6% year-over-‎year. ‎

    ‎Gevo Inc. (GEVO) grew over 10.12% at $4.68 in pre-market trading today.‎

    Before the trading started on January 04, 2021, Kinross Gold Corporation ‎‎(KGC) is up 4.9% to reach $7.7. It has been trading in a 52-week range of $2.72 to ‎‎$10.31.‎

    ‎Ocugen Inc. (OCGN), a Biotechnology company, rose about 125.14% at $4.12 ‎in pre-‎‎‎‎market trading Monday.‎

    ‎Color Star Technology Co. Ltd. (CSCW) stock plunged -9.79% to $0.6351 in the ‎pre-market trading. The company recently revealed strategic partnership with two UAE ‎companies. ‎

    ‎Avinger Inc. (AVGR) is up more than 8.16% at $0.476 in pre-market hours ‎Monday ‎January 04, 2021. The stock had dropped over -6.86% to $0.44 in the last trading ‎session.‎

    ‎Harmony Gold Mining Company Limited (HMY) stock soared 9.19% to $5.11 ‎in ‎the ‎pre-market trading. The most recent rating by JP Morgan, on February 21, 2019, is an ‎Overweight.‎

    ‎PEDEVCO Corp. (PED) is down more than -5.3% at $1.43 in pre-‎‎market ‎hours ‎Monday January 04, 2021. The stock had jumped over 20.80% to $1.51 in the last ‎trading ‎session.‎

    ‎Orbital Energy Group Inc. (NASDAQ: OEG) shares are trading up 5.02% at ‎‎$2.3 at ‎the ‎time of writing after pricing $10 million registered direct offering. Company’s 52-‎week ranged ‎between ‎‎$0.45 to $2.80.‎

    ‎Aethlon Medical Inc. (AEMD) is down more than -6.88% at $2.3 in pre-‎market ‎hours ‎Monday January 04, 2021. The stock had jumped over 19.32% to $2.47 in the last ‎trading session.‎

    Before the trading started on January 04, 2021, Invitae Corporation (NVTA) is ‎up 4.31% to reach $43.61. The company recently revealed that Sean George, co-founder and ‎chief executive officer of Invitae, will present at the 39th Annual J.P. Morgan Healthcare ‎Conference on Tuesday, January 12, 2021 at 10:50 a.m. Eastern/7:50 a.m. Pacific. It has been ‎trading in a 52-week range of $7.41 to $61.59.‎

    ‎Hall of Fame Resort & Entertainment Company (HOFV), a ‎Entertainment ‎company, ‎rose about 31.71% at $1.62 in pre-market trading Monday.‎

    ‎T2 Biosystems Inc. (TTOO) is down more than -3.23% at $1.2 in pre-‎market ‎hours ‎Monday January 04, 2021. The stock had dropped over -0.80% to $1.24 in the last ‎trading session.‎

    ‎Clearside Biomedical Inc. (NASDAQ: CLSD) shares are trading up 7.66% ‎at ‎‎$2.95 ‎at ‎the time of writing. Company’s 52-week ranged between $1.10 to $4.13. Analysts ‎have ‎a ‎consensus ‎price target of $8.‎

    ‎Teligent Inc. (NASDAQ: TLGT) shares are trading down -5.13% at $0.7115 at ‎the time of writing after declaring its financial results for the third quarter ended September ‎‎30, 2020. Company’s 52-week ranged between $0.46 to $6.46. Analysts have a consensus price ‎target of $2.‎

  • 23 Stocks Making Sharp Moves in Pre Market Session

    23 Stocks Making Sharp Moves in Pre Market Session

    ‎Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-‎market ‎trading after reporting that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy.‎

    ‎Tenax Therapeutics Inc. (NASDAQ: TENX) shares are trading down -7.07% at $1.84 ‎at ‎the time of writing. Company’s 52-week ranged between $0.25 to $2.68.‎

    ‎Ideanomics Inc. (IDEX) stock soared 2.87% to $2.15 in the pre-market trading. ‎The ‎company recently revealed that its Mobile Energy Global (“MEG”) and its contracting entity ‎Qingdao ‎Chengyang Medici have signed an agreement with Meihao Chuxing, a joint venture between ‎BYD and ‎Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Oxbridge Re Holdings Limited (OXBR) stock moved down -6.83 percent to $1.91 ‎in ‎the pre-market trading.‎

    ‎Guardion Health Sciences Inc. (NASDAQ: GHSI) shares are trading up 12.48% ‎at ‎‎$0.4289 at the time of writing. The firm lately declared the appointment of seasoned ‎nutritional ‎products industry leader Bret Scholtes as President and Chief Executive Officer. Company’s ‎‎52-week ‎ranged between $0.17 to $0.74.‎

    ‎Gevo Inc. (GEVO) is down more than -4.76% at $4.4 in pre-market ‎hours ‎Wednesday December 30, 2020. The stock had dropped over -4.15% to $4.62 in the last ‎trading ‎session.‎

    ‎Universal Security Instruments Inc. (UUU) stock moved up 5.0 percent to $5.25 ‎in ‎the pre-market trading following its statement regarding recent market activity in the ‎Company’s ‎stock.‎

    ‎Marathon Patent Group Inc. (MARA) gained over 10.03% at $12.94 in pre-‎market ‎trading Wednesday December 30, 2020. The company recently reported that it has entered ‎into a ‎contract with Bitmain to purchase 70,000 Antminer S-19 ASIC miners.‎

    Before the trading started on December 30, 2020, Ocugen Inc. (OCGN) is down -‎‎‎7.83% to reach $2.0. It has been trading in a 52-week range of $0.17 to $3.05.‎

    Before the trading started on December 30, 2020, Moderna Inc. (MRNA) is ‎up ‎‎3.59% to reach $118.5 following the declaration from the company that the it is engaged in ‎discussions ‎with the government of South Korea to potentially provide 40 million or more doses of the ‎Moderna ‎COVID-19 Vaccine to support South Korea’s aim of providing vaccines to the public as soon as ‎possible. ‎It has been trading in a 52-week range of $17.68 to $178.50.‎

    ‎Riot Blockchain Inc. (RIOT) stock soared 6.02% to $16.74 in the pre-market trading.‎

    ‎Technical Communications Corporation (NASDAQ: TCCO) shares are trading down -‎‎‎16.78% at $4.76 at the time of writing after declaring its results for the fiscal year ended September ‎‎26, ‎‎2020. Company’s 52-week ranged between $1.72 to $7.00.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) is up more than 2.21% at $0.6695 ‎in ‎pre-market hours Wednesday December 30, 2020. The stock had dropped over -6.16% to $0.65 in ‎the ‎last trading session.‎

    ‎AstraZeneca PLC (AZN) gained over 2.26% at $51.03 in pre-market ‎trading ‎Wednesday December 30, 2020 after receiving approval of its coronavirus vaccine in U.K.‎

    ‎New Concept Energy Inc. (AMEX: GBR) shares are trading down -14.75% at $2.08 ‎at ‎the time of writing. Company’s 52-week ranged between $0.55 to $2.19.‎

    ‎Moleculin Biotech Inc. (MBRX) stock plunged -1.67% to $0.8279 in the pre-‎market ‎trading after declaring that that the US Food and Drug Administration (FDA) has granted ‎Orphan Drug ‎Designation (ODD) to Annamycin for treatment of soft tissue sarcomas.‎

    ‎MoSys Inc. (MOSY), a Semiconductors company, dropped about -13.22% at $2.1 ‎in ‎pre-market trading Wednesday.‎

    Before the trading started on December 30, 2020, Greenpro Capital Corp. (GRNQ) ‎is ‎down -2.15% to reach $1.82. The company lately revealed that it intends to set up a Bitcoin ‎‎($BTC) ‎Fund for investment. It has been trading in a 52-week range of $0.21 to $3.12.‎

    ‎Nxt-ID Inc. (NXTD) gained over 9.92% at $1.44 in pre-market trading ‎Wednesday ‎December 30, 2020.‎

    ‎Hepion Pharmaceuticals Inc. (HEPA) gained over 50.0% at $3.12 in pre-‎market ‎trading Wednesday December 30, 2020 after declaring positive top line data for low dose ‎CRV431 in ‎Phase 2a ‘AMBITION’ clinical trial for treatment of Advanced NASH.‎

    ‎XPeng Inc. (XPEV) is up more than 3.13% at $42.85 in pre-market hours ‎Wednesday ‎December 30, 2020. The stock had jumped over 9.31% to $41.55 in the last trading session.‎

    ‎BioNTech SE (BNTX) is up more than 3.5% at $91.37 in pre-market hours ‎Wednesday ‎December 30, 2020 following declaration from the financial magazine Caixin that Shanghai ‎Fosun ‎Pharmaceutical Group will set up a joint venture with BioNTech to produce COVID-19 vaccines in ‎China. ‎The stock had jumped over 0.19% to $88.28 in the last trading session.‎

    Before the trading started on December 30, 2020, Bit Digital Inc. (BTBT) is up ‎‎14.58% ‎to reach $12.1. It has been trading in a 52-week range of $0.28 to $12.45.‎

  • Pre-Market Cues: 24 Stocks Roaring for Change On December 28th

    Pre-Market Cues: 24 Stocks Roaring for Change On December 28th

    ‎Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The ‎most recent rating by Ladenburg Thalmann, on March 09, 2018, is a Buy. The company lately ‎announced annual meeting results.‎

    ‎Jaguar Health Inc. (JAGX) is up more than 16.5% at $0.833 in pre-market ‎hours ‎Monday December 28, 2020 after signing second agreement for $6 million non-dilutive ‎financing ‎transaction involving the sale of royalty rights. The stock had dropped over -33.18% to $0.71 ‎in the last ‎trading session.‎

    ‎Ocugen Inc. (NASDAQ: OCGN) shares are trading up 52.84% at $2.69 at the time of ‎writing. Company’s 52-week ranged between $0.17 to $3.05.‎

    ‎Senseonics Holdings Inc. (SENS) tumbled over -13.63% at $0.786 in pre-market ‎trading today after declaring financial and operational business updates.‎

    ‎Naked Brand Group Limited (NAKD), a Apparel Manufacturing company, rose about ‎‎2.63% at $0.2145 in pre-market trading Monday after reporting that it has been granted an additional ‎‎180-day period, or until May 24, 2021.‎

    ‎Zomedica Corp. (ZOM) gained over 13.05% at $0.259 in pre-market trading Monday ‎December 28, 2020.‎

    Before the trading started on December 28, 2020, Sundial Growers Inc. (SNDL) is up ‎‎9.23% to reach $0.517. The company today declared concentrates license agreement with Simply ‎Solventless. It has been trading in a 52-week range of $0.14 to $3.88.‎

    ‎Acasti Pharma Inc. (ACST) stock soared 14.17% to $0.377 in the pre-market trading. ‎The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.‎

    ‎Camber Energy Inc. (AMEX: CEI) shares are trading down -7.62% at $0.97 at the time ‎of writing. Company’s 52-week ranged between $0.46 to $4.10.‎

    ‎NIO Limited (NIO), a Auto Manufacturers company, rose about 1.92% at $46.65 in ‎pre-market trading Monday.‎

    ‎FuelCell Energy Inc. (FCEL) stock moved up 10.0 percent to $13.53 in the pre-market ‎trading.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) gained over 7.86% at $0.7173 in pre-‎market trading Monday December 28, 2020. The firm recently revealed that it has completed the ‎purchase of an approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine ‎development and commercial scale manufacturing facility. ‎

    ‎Guardion Health Sciences Inc. (GHSI) is down more than -9.47% at $0.3097 in pre-‎market hours Monday December 28, 2020. The stock had dropped over -7.89% to $0.34 in the last ‎trading session.‎

    Before the trading started on December 28, 2020, Color Star Technology Co. Ltd. ‎‎(CSCW) is up 30.76% to reach $0.9284. It has been trading in a 52-week range of $0.31 to ‎‎$2.06.‎

    ‎Ampio Pharmaceuticals Inc. (AMPE) stock soared 8.49% to $2.3 in the pre-market ‎trading. The most recent rating by ROTH Capital, on December 19, 2019, is a Buy.‎

    ‎Blink Charging Co. (BLNK), a Specialty Retail company, rose about 4.24% at $51.6 in ‎pre-market trading Monday.‎

    ‎Nikola Corporation (NKLA) stock moved up 2.18 percent to $14.05 in the pre-market ‎trading.‎

    ‎Onconova Therapeutics Inc. (ONTX) gained over 3.39% at $0.4905 in pre-market ‎trading Monday December 28, 2020.‎

    Before the trading started on December 28, 2020, MicroVision Inc. (MVIS) is up ‎‎4.43% to reach $6.84. It has been trading in a 52-week range of $0.15 to $9.74.‎

    ‎Nano Dimension Ltd. (NNDM) stock plunged -13.51% to $7.62 in the pre-market ‎trading after pricing $250 million registered direct offering. The most recent rating by Maxim Group, on ‎October 21, 2016, is a Buy.‎

    ‎Plug Power Inc. (NASDAQ: PLUG) shares are trading up 5.37% at $37.49 at the time ‎of writing. Company’s 52-week ranged between $2.53 to $37.11. Analysts have a consensus price ‎target of $24.‎

    ‎Marathon Patent Group Inc. (MARA) grew over 31.23% at $14.33 in pre-market ‎trading today.‎

    ‎Riot Blockchain Inc. (RIOT), a Software – Application company, rose about 18.22% at ‎‎$15.51 in pre-market trading Monday.‎

    ‎Marathon Oil Corporation (MRO) stock moved up 3.32 percent to $6.85 in the pre-‎market trading.‎

  • Early Morning Vibes: Check Out These 4 hot Stocks Right Now

    Early Morning Vibes: Check Out These 4 hot Stocks Right Now

    On December 24, American stock indices closed in the green. The S&P 500 Index climbed 0.35% to 3690 points, the Dow Jones added 0.23%, the NASDAQ 0.29%. The news background on the eve of Christmas was weak. Fiscal stimulus prospects continued to be supportive. The tech sector was one of the growth leaders with 0.75%, while the energy sector looked the weakest and lost 0.63%.

    Corporate news

    The State Administration for Market Regulation of the People’s Republic of China has suspected Alibaba Group (BABA: -13.4%) of violating antitrust laws. At the same time, the People’s Bank of China demands to reform the business of the fintech division of Alibaba Ant Group.

    The FDA has paused clinical trials for an anti-clotting vaccine developed by Altimmune (ALT: -9.3%) and is demanding additional data. 

    Today, world stock markets are showing mostly positive dynamics. On Sunday, December 27, President Donald Trump signed into law a $ 900 billion economic support bill that will include a one-time payment of $ 600 per person to Americans. Earlier, the president insisted on increasing the amount of payments to $ 2,000. A vote in Congress on this issue will take place today. If approved, this measure will be included in a separate bill. However, it is unlikely that the Republicans will support the initiative. Trump’s approval of the stimulus package is positive for the stock market, but some of these expectations have already been incorporated into quotes, and no new stimulus is expected in the short term. Thus, market response to these developments will be very limited, especially given the reduced volatility and trading volumes.

    Investors’ attention from the stimulus package will gradually shift to the front of the fight against coronavirus. According to US chief infectious disease specialist Anthony Fauci, “the worst” is yet to come, as the holidays will trigger a surge in COVID-19. However, most of all investors are now interested in the rate of vaccination of the population, because if it does not correspond to the original plans, it will lead to a correction in cyclical sectors.
    Technical picture

    Technically, the S&P 500 is prone to consolidation. The trading session the day before did not change the overall picture. Volatility will remain low ahead of the New Year. The RSI and MACD indicators continue to form bearish divergence, so the risk of correction remains.

    Today Top Movers‎

    ‎NXT-ID Inc (NXTD)‎‎ is up 42.74% at $1.77 in premarket trading session on Monday.‎

    ‎Ocugen, Inc (OCGN)‎‎ reported an increase of 44.32%, with the share price at $2.54 in today’s premarket trading session following the appointment of a vaccine scientific advisory board.‎

    ‎Jaguar Health Inc (JAGX)‎‎ share price gained 21.67% at $0.87 in early morning trading session on Monday. The firm recently signed second agreement for $6 million non-dilutive financing transaction involving the sale of royalty rights related to future Mytesi (Crofelemer) and Lechlemer revenue stream.

    ‎‎Naked Brand Group Ltd (NAKD)‎‎ share price soared 1.91% at $0.21 on Monday during premarket trading session after declaring that it has been granted an additional 180-day period, or until May 24, 2021.‎

    Latest Insider Activity


    Workhorse Group Inc. (WKHS) Director Chess Raymond Joseph announced the sale of shares taking place on Dec 18 at $21.05 for some 5,000 shares. The total came to more than $0.11 million.
     

    Invitae Corporation (NVTA) President & CEO George Sean E sold on Dec 22 a total 631,018 shares at $53.06 on average. The insider’s sale generated proceeds of almost $0.19 million.
     

    Neoleukin Therapeutics Inc. (NLTX) Director BAKER BROS. ADVISORS LP declared the purchase of shares taking place on Jul 07 at $15.25 for some 424,000 shares. The transaction amount was around $6.47 million.
     

    Odonate Therapeutics Inc. (ODT) Chief Executive Officer TANG KEVIN C bought on Dec 23 a total 15,514,566 shares at $15.58 on average. The purchase cost the insider an estimated $2.17 million.

    Earnings To Watch

    Top US earnings releases scheduled for today include Secoo Holding Limited (NASDAQ:SECO). It will announce its Jun 2019 financial results. The company is expected to report revenues of $241.41M in the three-month period.